IP Library Granted Patent US 9,192,635
Granted Patent B2
US 9,192,635 · App. 13/135,125 · Granted Nov 24, 2015

Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide

Inventors: Alexander L. Huang (Menlo Park, CA); Gin Wu (San Rafael, CA)
Assignee: LIVELEAF, INC.
A61K36/00A61K31/353A61K33/40A61K36/185A61K36/82A61K31/7024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,192,635
App. No.
13/135,125
Granted
Nov 24, 2015
Kind
B2
Abstract

The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.

Claims (11)

1. A method of treating a damaged mucosal, or gastrointestinal tissue, the method comprising: administering an effective amount of a composition to the damaged tissue of a subject in need thereof, the composition comprising hydrogen peroxide and a mixture of an aqueous pomegranate extract and an aqueous green tea extract wherein the mixture comprises phenolic compounds; wherein the composition is prepared by combining the mixture with hydrogen peroxide to form an aqueous solution such that the final concentration of hydrogen peroxide in the solution is 0.05-3%;

the mixture to hydrogen peroxide ratio in the composition is about 1:2 to about 1:20 on a molar weight basis;

the hydrogen peroxide is releasably bound to the phenolic compounds of the mixture;

the composition is bioactivated at a target site having a peroxidase or oxidase that is expressed in response to the tissue damage; and

the composition contains no unbound hydrogen peroxide prior to the bioactivating at the target site;

wherein the composition functions as an antitoxin when bioactivated at the target site of the damaged mucosal, or gastrointestinal tissue and assists in the healing of the damaged tissue by inactivating toxic compounds at the target site.

2. The method of claim 1 , wherein the mixture comprises a flavanol.

3. The method of claim 1 , wherein the mixture comprises a catechin.

4. The method of claim 1 , wherein the mixture comprises gallic acid, epigallic acid, or a combination thereof.

5. The method of claim 1 , wherein the damaged tissue is mucosal tissue.

6. The method of claim 1 , wherein the damaged tissue is gastrointestinal tissue.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2022
From: LIVELEAF, INC.
To: LIVELEAF HOLDINGS LLC.
Reel/Frame 061506/0296 →
CHANGE OF ADDRESS Recorded Oct 20, 2022
From: LIVELEAF, INC.
To: LIVELEAF, INC.
Reel/Frame 061733/0245 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECTIVE ASSIGNMENT TO RE-RECORD ASSIGNMENT PREVIOUSLY RECORDED ON REEL 031783 FRAME 0457. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTING THE ASSIGNEE FROM METAACTIV, INC. TO METAACTIV CORPORATION. Recorded Feb 16, 2014
From: HUANG, ALEXANDER L.; WU, GIN
To: METAACTIV CORPORATION
Reel/Frame 032265/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2013
From: HUANG, ALEXANDER L; WU, GIN
To: METAACTIV, INC.
Reel/Frame 031783/0457 →
MERGER Recorded Oct 24, 2012
From: LIVELEAF, INC.
To: LIVELEAF, INC., A DELAWARE CORPORATION
Reel/Frame 029186/0596 →
CHANGE OF NAME Recorded Oct 24, 2012
From: METAACTIV CORPORATION
To: LIVELEAF, INC.
Reel/Frame 029190/0393 →
Continuity (1)
Related Publication 20120328710A1 · Dec 27, 2012